This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Share public link

The 12th edition introduces specific chapters that address contemporary global health challenges and evolving scientific understanding:

Guided by new editors—Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox—the 12th edition brings a fresh perspective while maintaining the rigorous standards expected of this textbook.

The 12th edition is far more than a routine update; it is a thorough revision that addresses the most dynamic and impactful areas of modern gastroenterology. The text has been meticulously expanded and enhanced to reflect the rapid pace of discovery and clinical innovation.

Helmed by a distinguished editorial team consisting of , this newly revised two-volume masterwork spans over 2,500 pages of rigorously updated, evidence-based science. It bridges the gap between basic pathophysiology and cutting-edge clinical management, making it an essential purchase for modern medical libraries. Evolution of a Medical Masterpiece

: Offering a trusted reference for managing systemic diseases with profound gastrointestinal and hepatic manifestations.

For over 50 years, Sleisenger and Fordtran's Gastrointestinal and Liver Disease has served as the definitive reference for gastroenterology and hepatology professionals worldwide. The 12th edition (published December 2025) continues this legacy, offering a comprehensive, two-volume masterwork that synthesizes the expertise of hundreds of global leaders to provide up-to-date information on the diagnosis, management, and treatment of gastrointestinal and liver diseases.

Perhaps no area has grown faster than our understanding of the gut microbiome. The new edition provides updated insights into how microbial imbalances contribute to inflammatory bowel disease (IBD), obesity, and even systemic metabolic health.

In an era where medical knowledge evolves at a breakneck pace, the 12th edition arrives as an essential update, bridging the gap between cutting-edge research and bedside practice. What’s New in the 12th Edition?

The 12th edition is more than just a textbook; it is a comprehensive clinical partner. By integrating the latest genomic data, therapeutic breakthroughs, and diagnostic technologies, it ensures that practitioners are equipped to provide the best possible care for patients with digestive and liver disorders.

The 12th edition remains available for purchase at major retailers like Amazon , Barnes & Noble , and VitalSource .

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a significant update that reflects the latest advances in the field of gastroenterology. Some of the key features of this edition include:

The 12th edition is packed with significant updates, new chapters, and expanded discussions that reflect the latest advancements in gastroenterology and hepatology. The text has been meticulously revised to present everything from basic science to the newest techniques and technologies. Key new features and discussions include:

The 12th edition provides exhaustive coverage of both gastrointestinal and liver systems, organized logically for ease of use. Key sections include: 1. Biology and Pathophysiology

: Managed by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox, ensuring the content reflects current leadership in the field. Critical Reception

: A new chapter dedicated to the long-term and acute impacts of COVID-19 on the digestive system. Cancer Immunotherapy Side Effects